Arqule Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Arqule inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Arqule Inc Today - Breaking & Trending Today

Cyclacel Pharmaceuticals Announces the Appointment of Brian Schwartz, M.D. as Chief Medical Officer

Cyclacel Pharmaceuticals Announces the Appointment of Brian Schwartz, M.D. as Chief Medical Officer
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

South Africa , Spiro Rombotis , Brian Schwartz , Mark Kirschbaum , Paul Mcbarron , Cyclacel Pharmaceuticals Inc , Head Of Research Development , Merck Co , University Of Toronto , Arqule Inc , Exchange Commission , University Of Pretoria , Chief Medical Officer , Chief Executive , Senior Vice President , Board Member , Cyclacel Pharmaceuticals , Annual Report , All Rights ,

First in human trial of new drug raises hopes

<p>A new targeted drug, studied by researchers at <a href="https://cancer.osu.edu/">The Ohio State University Comprehensive Cancer Center &ndash; Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC &ndash; James)</a>, may&nbsp;offer&nbsp;a new treatment option for patients with blood cancers, including chronic lymphocytic leukemia and Non-Hodgkin lymphoma&nbsp;whose disease has stopped responding to standard treatments.</p>
....

United States , University Of Cincinnati , Ohio State University , Lindsey Granlund , Mohammed Farooqui , Brian Schwartz , Sudharshan Eathiraj , Jennifer Woyach , Arthurg James , Elizabeth Muhowski , Ian Flinn , Deborah Stephens , Johnc Byrd , Wayne Wang , Sean Reiff , Lyndsey Szuszkiewicz , Razi Ghori , Feng Chai , Method Of Research , Merck Co , Leukemia Research Program , Sarah Cannon Research Institute , Huntsman Cancer Institute , Richardj Solove Research Institute , Ohio State University Comprehensive Cancer Center , University Of Cincinnati College Medicine ,

Targeted drug may offer a new treatment option for patients with relapsed blood cancer

A new targeted drug, studied by researchers at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James), may offer a new treatment option for patients with blood cancers, including chronic lymphocytic leukemia (CLL) and Non-Hodgkin lymphoma (NHL) whose disease has stopped responding to standard treatments. ....

United States , Elizabeth Muhowski , Mohammed Farooqui , Johnc Byrd , Ian Flinn , Feng Chai , Lindsey Granlund , Arthurg James , Sudharshan Eathiraj , Sean Reiff , Brian Schwartz , Lily Ramsey , Wayne Wang , Lyndsey Szuszkiewicz , Deborah Stephens , Jennifer Woyach , Razi Ghori , Ohio State University Comprehensive Cancer Center , Merck Co , University Of Cincinnati College Medicine , Huntsman Cancer Institute , Leukemia Research Program , Arqule Inc , Richardj Solove Research Institute , Sarah Cannon Research Institute , Cancer Hospital ,